Predictors of response to erenumab after 12 months of treatment.

Baraldi CarloFlavia Lo CastroMaria Michela CainazzoLuca PaniSimona Guerzoni

Published in: Brain and behavior (2021)

Patients with longer medication overuse-headache duration, higher analgesic intake, and a higher number of previous preventive treatment failures may receive less benefit with erenumab.

Keyphrases

healthcare
spinal cord injury
body mass index
combination therapy
weight loss
anti inflammatory